非酒精性脂肪性肝病女性失去心血管疾病保护作用:纵向队列研究
该研究基于美国Olmsted County 1997-2014年NAFLD患者及年龄性别匹配的参照人群,发现女性性别在一般人群中可保护缺血性心血管事件(HR=0.71,95%CI 0.62-0.80,P<0.001),但在NAFLD患者中该保护作用显著减弱(HR=0.90,95%CI 0.74-1.08,P=0.25),且NAFLD女性心血管事件和死亡超额风险高于男性。
要点
- 女性性别对一般人群缺血性心血管事件有保护作用,HR=0.71。
- NAFLD女性该保护作用消失,HR=0.90,P=0.25。
- NAFLD女性心血管事件(18% vs 9%)和死亡(9% vs 6%)超额风险高于男性。
核心结论
- NAFLD女性失去女性性别带来的心血管保护作用,当前临床评估方法低估其风险。
研究设计与样本
- 纵向队列研究,纳入1997-2014年Olmsted County诊断的NAFLD成人3869例及年龄性别匹配(1:4)参照人群15209例。
主要发现
- 中位随访7年(范围1-20年)记录3851例心血管事件。
- 一般人群中女性性别对缺血性心血管事件有保护作用(HR=0.71,95%CI 0.62-0.80,P<0.001)。
- NAFLD患者中女性性别保护作用显著减弱(HR=0.90,95%CI 0.74-1.08,P=0.25)。
- NAFLD女性心血管疾病超额事件18% vs 男性9%,死亡超额事件9% vs 男性6%。
临床怎么用
- 临床中应认识到NAFLD女性心血管风险被低估,需更积极评估和管理心血管危险因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Cardiovascular (CV) disease is the top cause of mortality in patients with nonalcoholic fatty liver disease (NAFLD). Female sex is protective against CV disease. We aimed to determine whether female sex remains a protective factor against CV disease (myocardial infarction, angina, and stroke) in NAFLD. METHODS: We identified all adults diagnosed with NAFLD in Olmsted County, Minnesota, between 1997 and 2014 and selected an age- and sex-matched (1:4) referent cohort from the general population. NAFLD was ascertained using a code-based algorithm with high validity tested by medical record review. The impact of female sex on incident CV events was examined using Cox proportional hazards regression analysis stratified by standard clinical risk factors. RESULTS: A total of 3,869 NAFLD and 15,209 age- and sex-matched referent subjects were identified. After a median follow-up time of 7 (range 1-20) years, 3,851 CV events were recorded. Female sex was protective for ischemic CV events in the general population (hazard ratio = 0.71, 95% confidence interval 0.62-0.80, P < 0.001), but the impact was significantly diminished among those with NAFLD (hazard ratio = 0.90, 95% confidence interval 0.74-1.08, P = 0.25), even after stratification by time-dependent CV risk factors and control for diagnostic testing (liver enzymes and ultrasound) during routine medical evaluations, as a surrogate of access to care. Among those with NAFLD, excess events were higher in women than in men: CV disease (18% vs 9%) and mortality (9% vs 6%). DISCUSSION: Women with NAFLD lose the CV protection conferred by the female sex, and their risk is underestimated by current estimating methods in clinical practice.
引用
- Allen AM, Therneau TM, Mara KC, et al. Women With Nonalcoholic Fatty Liver Disease Lose Protection Against Cardiovascular Disease: A Longitudinal Cohort Study. Am J Gastroenterol. 2019. PMID: 31577570. doi:10.14309/ajg.0000000000000401
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。